Issue Date: January 15, 2007
Back To Basics
During the first four years of the decade, Genencor was an industrial enzymes producer with high aspirations: It wanted to parlay its biotechnology skills into success in the lucrative pharmaceutical industry.
But everything changed in early 2005, when Danisco, a Danish food and feed ingredients company and one of Genencor's two large shareholders, struck a deal to buy out Eastman Chemical, the other big shareholder. Danisco then snapped up Genencor's publicly traded shares . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society